Cargando…
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
In metabolic conditions such as obesity and diabetes, which are associated with deregulated signaling of the insulin/insulin-like growth factor system (IIGFs), inflammation plays a dominant role. In cancer, IIGFs is implicated in disease progression, particularly during obesity and diabetes; however...
Autores principales: | Vella, Veronica, Lappano, Rosamaria, Bonavita, Eduardo, Maggiolini, Marcello, Clarke, Robert Bryan, Belfiore, Antonino, De Francesco, Ernestina Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335176/ https://www.ncbi.nlm.nih.gov/pubmed/36869790 http://dx.doi.org/10.1210/endrev/bnad005 |
Ejemplares similares
-
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling
por: Vella, Veronica, et al.
Publicado: (2020) -
DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System
por: Vella, Veronica, et al.
Publicado: (2021) -
Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer
por: Muoio, Maria Grazia, et al.
Publicado: (2021) -
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
por: Belfiore, Antonino, et al.
Publicado: (2023) -
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)